Filing Details
- Accession Number:
- 0000950103-21-010821
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-07-20 18:11:00
- Reporting Period:
- 2021-07-17
- Accepted Time:
- 2021-07-20 18:11:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1356090 | Precigen Inc. | PGEN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1724195 | Helen Sabzevari | 20374 Seneca Meadows Parkway Germantown MD 20876 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-07-17 | 25,000 | $0.00 | 730,057 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-07-19 | 12,531 | $5.43 | 717,526 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | Disposition | 2021-07-17 | 25,000 | $0.00 | 25,000 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit ('RSU") represents a contingent right to receive one share of Precigen common stock.
- This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of RSUs.
- The RSUs were granted on March 28, 2018 and have vested in full.